| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.89B | +7.5% |
| Gross profit | ¥0.29B | — |
| Operating income | ¥0.04B | — |
| Net income | ¥0.04B | +9.5% |
| Gross margin | 32.2% | Net margin 4.2% |
| Revenue Q/Q | -31.0% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.60B | 67.8% |
| R&D | ¥0.04B | 4.8% |
| SG&A | ¥0.22B | 24.5% |
| Tax & other | ¥-0.00B | -0.0% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
天华新能 ・ 中来股份 ・ 菲利华 ・ ST迪瑞 ・ 天和防务 ・ 飞凯材料 ・ 天利科技 ・ 劲拓股份 ・ 花园生物 ・ 宝色股份 ・ 汉宇集团 ・ 博济医药
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies